FDCDDQ
CGEM icon

Federation des caisses Desjardins du Quebec’s Cullinan Oncology CGEM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55K Sell
250
-1,750
-88% -$26K ﹤0.01% 2615
2026
Q1 		$28.4K Buy
+2,000
New +$25.7K ﹤0.01% 2018
2025
Q4 		– Sell
-6,000
Closed -$35.6K – 2906
2025
Q3 		$35.6K Buy
+6,000
New +$43.9K ﹤0.01% 1892

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CGEM Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Cullinan Oncology (CGEM) stake by 88% in Q2 2026, selling an estimated $26K and leaving 250 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Federation des caisses Desjardins du Quebec first reported a position in CGEM in Q3 2025 and has held it in 3 quarters since. The position peaked at $35.6K in Q3 2025. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 250 shares of Cullinan Oncology worth $4.55K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec sold 1,750 Cullinan Oncology shares in Q2 2026, an estimated $26K.
  • Cullinan Oncology made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2615 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Cullinan Oncology in Q3 2025 and has held it in 3 quarters since.
  • Federation des caisses Desjardins du Quebec's Cullinan Oncology position peaked at $35.6K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.